Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Thioglycolic Acid

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
Phase 4 (2)

Trial Status

Completed2
Unknown1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT05672407Phase 4Withdrawn

The Role of Local Tranexamic Acid on Periorbital Oculoplastic Surgery

NCT04745078Not ApplicableCompletedPrimary

Carboxytherapy for Periorbital Dark Circles

NCT03238105Phase 4UnknownPrimary

Treatment of Periorbicular Hyperchromia Comparing 10% Thioglycolic Acid Peeling Versus Pulsed Intense Light

NCT03393624CompletedPrimary

Influence of Sleep Quality in Patients With Periorbicular Hyperchromia

Showing all 4 trials

Research Network

Common Treatments

  • Thioglycolic Acid1
  • Tranexamic Acid1
  • Caboxy601
  • Intense Pulsed Light1
  • Caboxy301

Active Sponsors

  • Hospital de Clinicas de Porto Alegre2
  • University of Miami1
  • Alexandria University1

Top Investigators

Related Conditions

  • Surgical Blood Loss1
  • Hemorrhage1
  • Eyelid Diseases1

Activity Timeline